Anne Stidsholt Roug (Anne S Roug)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Replacement Therapy

Newly Diagnosed

Top Venues

Leukemia & lymphoma

Future oncology (London, England)

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
The use of metformin and risk of myeloproliferative neoplasms among patients with no registered markers of diabetes. Blood advances (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms - a Danish population-based case-control study. Blood advances (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study. Blood advances 8 (16) (2024)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Carl Hasselbalch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug
Metformin use and risk of myeloproliferative neoplasms: a Danish population-based case-control study. Blood advances 8 (16) (2024)
Carlos Jimenez Chillon, Jad Othman, David Taussig, Carlos Jiménez-Vicente, Alexandra Martínez-Roca, Ing Soo Tiong, Manish Jain, James Aries, Seda Cakmak, Stephen Knapper, Daniel Tuyet Kristensen, Vidhya Murthy, Zacharoula Galani, Charlotte Kallmeyer, Loretta Ngu, David Veale, Simon Bolam, Nina Orfali, Anne Parker, Cara Manson, Jane Parker, Thomas Erblich, Deborah Susan Richardson, Katya Mokretar, Nicola Potter, Ulrik Malthe Overgaard, Anne Stidsholt Roug, Andrew H Wei, Jordi Esteve, Martin Jädersten, Nigel H Russell, Richard Dilon
Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML. Blood advances (2023)
Daniel Tuyet Kristensen, Rasmus Froberg Brøndum, Andreas Due Ørskov, Claus Werenberg Marcher, Claudia Schöllkopf, Anne Louise Tølbøll Sørensen, Marianne Tang Severinsen, Martin Bøgsted, Anne Stidsholt Roug
Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy. European journal of haematology (2023)
Daniel Tuyet Kristensen, Lars Børty Nielsen, Lasse Hjort Kyneb Jakobsen, Tove-Christina Choe Kristensen, Lene Østergaard Jepsen, Claudia Schöllkopf, Kim Theilgaard-Mönch, Tarec Christoffer El-Galaly, Anne Stidsholt Roug, Marianne Tang Severinsen
Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study. British journal of haematology 199 (4) (2022)
Rasmus Froberg Brøndum, Anne Sig Sørensen, Lars Børty, Charles Vestereghem, Anne S Rytter, Marlene M Nielsen, Marianne Tang Severinsen, Paw Jensen, Henrik Gregersen, Tarec Christoffer El-Galaly, Karen Dybkær, Lars Holger Ehlers, Martin Bøgsted, Anne Stidsholt Roug
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system. Future oncology (London, England) 17 (25) (2021)
Therese Marie Henriette Naur, Lasse Hjort Kyneb Jakobsen, Anne Stidsholt Roug, Tarec Christoffer El-Galaly, Claus Werenberg Marcher, Jan Maxwell Nørgaard, Kim Theilgaard-Mönch, Peter Møller, Claudia Schöllkopf, Marianne Tang Severinsen
Treatment intensity and survival trends among real-world elderly AML patients diagnosed in the period 2001-2016: a Danish nationwide cohort study. Leukemia & lymphoma 62 (8) (2021)